SCHEMBL6566483

SCHEMBL6566483

COC(=O)c1cc(NC(=O)NCCc2cccnc2)ccc1OC(c1ccccc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.51
CASR P41180 1/20 0.49
PRMT3 O60678 1/20 0.49
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
KMT2A Q03164 1/20 0.47
HSD17B10 Q99714 1/20 0.47
EPHX1 P07099 1/20 0.44
ADRB2 P07550 1/20 0.44
ADRB1 P08588 1/20 0.44
ADRB3 P13945 1/20 0.44
ROCK2 O75116 2/20 0.44
ROCK1 Q13464 2/20 0.44
RAB9A P51151 1/20 0.44
NAMPT P43490 4/20 0.44
POLB P06746 2/20 0.43
ITGB3 P05106 1/20 0.43
ITGAV P06756 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6565755 0.91 L3MBTL1 (0.63) L3MBTL1KDM4EALDH1A1HPGDTSHR
SCHEMBL6566680 0.91 CASR (0.56) CASRPRMT3KMT2AEPHX1ROCK2
SCHEMBL6564652 0.90 CASR (0.52) CASRPRMT3KDM4EALDH1A1KMT2A
SCHEMBL6566630 0.86 PRMT3 (0.46) L3MBTL1PRMT3KMT2AADRB2ADRB1
SCHEMBL6566611 0.85 CASR (0.54) CASRKDM4EALDH1A1KMT2AEPHX1
SCHEMBL6564606 0.84 CNR1 (0.58) CASRALDH1A1KMT2APOLB
SCHEMBL6567020 0.83 KDM4E (0.51) L3MBTL1CASRKDM4EALDH1A1HPGD
SCHEMBL6566826 0.83 GAA (0.54) L3MBTL1CASRKDM4EALDH1A1KMT2A
SCHEMBL6566529 0.82 ALDH1A1 (0.56) L3MBTL1CASRALDH1A1ROCK2ROCK1
SCHEMBL6565899 0.82 CASR (0.72) CASRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 L3MBTL1 2613/4885CASR 1621/4885PRMT3 965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.